These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8971133)

  • 1. Retention mechanism of imidazoles in connective tissue. I. Binding to elastin.
    Ohta K; Yamaguchi JI; Akimoto M; Fukushima K; Suwa T; Awazu S
    Drug Metab Dispos; 1996 Dec; 24(12):1291-7. PubMed ID: 8971133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Covalent binding of radioactivity from [14C]rofecoxib, but not [14C]celecoxib or [14C]CS-706, to the arterial elastin of rats.
    Oitate M; Hirota T; Koyama K; Inoue S; Kawai K; Ikeda T
    Drug Metab Dispos; 2006 Aug; 34(8):1417-22. PubMed ID: 16679386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retention mechanism of imidazoles in connective tissue. IV. Identification of a nucleophilic imidazolone metabolite in rats.
    Ohta K; Fukasawa Y; Yamaguchi J; Kohno Y; Fukushima K; Suwa T; Awazu S
    Biol Pharm Bull; 1998 Dec; 21(12):1334-7. PubMed ID: 9881649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retention mechanism of imidazoles in connective tissue. II. Activation of imidazoles in cupro-ascorbate system for irreversible binding formation with aortic tissue in vitro.
    Ohta K; Akimoto M; Kohno Y; Fukushima K; Suwa T; Awazu S
    Biol Pharm Bull; 1998 Mar; 21(3):308-10. PubMed ID: 9556167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism for covalent binding of rofecoxib to elastin of rat aorta.
    Oitate M; Hirota T; Takahashi M; Murai T; Miura S; Senoo A; Hosokawa T; Oonishi T; Ikeda T
    J Pharmacol Exp Ther; 2007 Mar; 320(3):1195-203. PubMed ID: 17164475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Covalent binding of rofecoxib, but not other cyclooxygenase-2 inhibitors, to allysine aldehyde in elastin of human aorta.
    Oitate M; Hirota T; Murai T; Miura S; Ikeda T
    Drug Metab Dispos; 2007 Oct; 35(10):1846-52. PubMed ID: 17620346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of carbon disulfide on the metabolism of connective tissue of rats' aorta and lungs].
    Wegrowski J
    Med Pr; 1980; 31(1):13-9. PubMed ID: 7374431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in the connective tissue components of the aorta in thymectomized rats.
    Prodanov K; Velkov Z; Tsakova L; Kemileva Z
    Cor Vasa; 1988; 30(4):309-16. PubMed ID: 3168487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Metabolic indices in the connective tissue in experimental hyper- and hypovitaminosis K].
    Sharaev PN
    Farmakol Toksikol; 1978; 41(2):189-90. PubMed ID: 149021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 2nd communication: distribution to organs and tissues in male, female and pregnant rats, and characteristics of protein binding in plasma.
    Steinke W; Ahr HJ; Hirayama M
    Arzneimittelforschung; 1997 Aug; 47(8):939-48. PubMed ID: 9296280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
    Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
    Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics, protein binding and metabolic profile of 3H-icometasone enbutate following intravenous, oral and intratracheal administrations to Sprague-Dawley rats.
    Duchêne P; Giudicelli MD; Neau B; Gronfier A; Firmin Y; Villax P; Saivin S; Houin G
    Arzneimittelforschung; 1998 Apr; 48(4):371-8. PubMed ID: 9608879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in the composition of the thoracic aortic wall in spontaneously hypertensive rats treated with losartan or spironolactone.
    Han WQ; Wu LY; Zhou HY; Zhang J; Che ZQ; Wu YJ; Liu JJ; Zhu DL; Gao PJ
    Clin Exp Pharmacol Physiol; 2009 May; 36(5-6):583-8. PubMed ID: 19673944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate. 1st communication: absorption, distribution and excretion after single administration of 14C-labeled compound to rats and dogs.
    Nakamura A; Sugihara K; Hirota T; Morino A; Ezumi Y; Takaichi M
    Arzneimittelforschung; 1997 Feb; 47(2):151-9. PubMed ID: 9079234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Morphological and biochemical changes in the connective tissue in chronic chloroacetophone poisoning].
    Antov G; Kazakova B; Popov T
    Probl Khig; 1984; 9():59-65. PubMed ID: 6483829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the antifungal activity of the new imidazole antimycotic lanoconazole in infected sites. Distribution in the skin and in vitro activity in the presence of stratum corneum.
    Niwano Y; Matsui M; Tabuchi T; Kanai K; Hamaguchi H; Miyazaki T; Uchida K; Yamaguchi H
    Arzneimittelforschung; 1997 Sep; 47(9):1056-60. PubMed ID: 9342423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 4th communication: absorption, metabolism, excretion and plasma protein binding in various animals and man.
    Mizojiri K; Okabe H; Sugeno K; Misaki A; Ito M; Kominami G; Esumi Y; Takaichi M; Harada T; Seki H; Inaba A
    Arzneimittelforschung; 1997 Mar; 47(3):259-69. PubMed ID: 9105544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of miglitol. Absorption, distribution, metabolism, and excretion following administration to rats, dogs, and man.
    Ahr HJ; Boberg M; Brendel E; Krause HP; Steinke W
    Arzneimittelforschung; 1997 Jun; 47(6):734-45. PubMed ID: 9239452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of prulifloxacin. 1st communication: absorption, distribution and excretion in rats, dogs and monkeys after a single administration.
    Okuyama Y; Momota K; Morino A
    Arzneimittelforschung; 1997 Mar; 47(3):276-84. PubMed ID: 9105546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue distribution and excretion of myosmine after i.v. administration to Long-Evans rats using quantitative whole-body autoradiography.
    Glas S; Tyroller S; Zwickenpflug W; Steiner K; Kiefer G; Richter E
    Arch Toxicol; 2007 Mar; 81(3):151-61. PubMed ID: 16902802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.